CD64/Fc gamma RI is a granulo-monocytic lineage marker on CD34+ hematopoietic progenitor cells

J Olweus1, F Lund-Johansen, L W Terstappen

  • 1Becton Dickinson Immunocytometry Systems, San Jose, CA 95131-1807, USA.

Blood
|May 1, 1995
PubMed

Insights

CD64 is identified as a specific marker for granulo-monocytic progenitor cells, distinguishing them from other cell types. This finding aids in the precise identification and purification of these crucial myeloid precursor cells.

Area of Science:

  • Hematology
  • Immunology
  • Cell Biology

Background:

  • Identifying specific markers for hematopoietic progenitor cell commitment is crucial for understanding blood cell development and for therapeutic applications.
  • Previous markers like CD13 and CD33 were found to be expressed on non-committed progenitor cells, limiting their specificity.
  • The need for a reliable marker to distinguish granulo-monocytic progenitors from other lineages persists.

Purpose of the Study:

  • To identify novel cell surface markers that are specific for the granulo-monocytic commitment of progenitor cells.
  • To evaluate the utility of CD64 as a marker for granulo-monocytic progenitor cells.
  • To compare the specificity and expression timing of CD64 with other myeloid markers like CD15, CD13, and CD33.

Main Methods:

  • Screening of large antibody panels against CD34+ progenitor cells from fetal and adult bone marrow.
  • Flow cytometric analysis to assess marker expression and cell scatter properties.
  • Colony-forming assays (CFU-GM, BFU-E/CFU-E) in semisolid medium.
  • Four-color immunofluorescence and cell sorting to analyze progeny in liquid culture.

Main Results:

  • CD64 was found to be expressed on lineage-committed progenitor cells (CD34+, CD38+) but not on non-committed progenitors (CD34++, CD38-/lo, HLA-DR+).
  • CD34+, CD64+ cells predominantly generated granulomonocytic colonies (98%) and cells (83%), including neutrophils, basophils, and monocytes/macrophages.
  • In contrast, CD34+, CD64- cells primarily generated erythroid lineages (63% BFU-E/CFU-E, 81% erythroid cells).
  • CD64 expression was observed earlier in differentiation than CD15, making it a more reliable marker for early granulo-monocytic progenitors.

Conclusions:

  • CD64 is a highly specific and reliable marker for the identification and purification of granulo-monocytic progenitor cells.
  • CD64 expression precedes that of CD15 during myeloid differentiation, offering an advantage for early progenitor identification.
  • This study provides a valuable tool for research in hematopoiesis and potential clinical applications in myeloid cell-related disorders.